or
Looking to list your PhD opportunities? Log in here.
Evropi Theodoratou is a Professor of Cancer Epidemiology and Global Health at the University of Edinburgh, a position held since 2019. They have a diverse academic background, having obtained a BSc in Biology from Aristotle University of Thessalonica, Greece, in 2003, followed by an MSc in Medical Biology from the University of Linkoping, Sweden, in 2004. They completed a PhD in Cancer Epidemiology at the University of Edinburgh in 2009. Prior to their current role, they served as a Reader at the University of Edinburgh from 2017 to 2019, and as a Senior Lecturer/Chancellor’s Fellow from 2014 to 2017. Their early career included positions as a post-doctoral research fellow and a CRUK Population research post-doctoral fellow at the University of Edinburgh from 2009 to 2014. They are also a CRUK Career Development Fellow since 2017 and co-lead the UNCOVER network, which focuses on COVID-19 evidence reviews. Their research primarily centres on colorectal cancer epidemiology, employing genetic, molecular, and clinical epidemiology methodologies. They hold six personal awards as Principal Investigator or co-investigator and are actively involved in developing new research methods related to empirical research and evidence-based medicine.
Professor Theodoratou's primary research interest is in colorectal cancer epidemiology, focusing on projects in genetic, molecular, and clinical epidemiology. They hold a CRUK Career Development Fellowship aimed at improving bowel cancer identification for individuals with bowel symptoms, utilising population screening and diagnostic pathways to reduce the overall death rate and enhance survival outcomes. Another active research area involves applying phenome-wide association study methodology (PheWAS) to explore associations between specific genetic variations or biomarker levels and multiple clinical outcomes. Additionally, they are interested in developing and applying new research methods related to empirical research and evidence-based medicine. Professor Theodoratou co-leads UNCOVER, a network of population health researchers and information specialists dedicated to providing evidence reviews for policymakers in response to the COVID-19 pandemic.
Harry Campbell is a Professor of Genetic Epidemiology and Public Health at the University of Edinburgh, affiliated with the Usher Institute within the College of Medicine and Veterinary Medicine. He holds a BMedSci Hons (1st; Pharmacology), an MBChB, and an MD, all from Edinburgh, along with an MSc (distinction) from the London School of Hygiene & Tropical Medicine. He is a member of several professional bodies, including MRCP, FRCP, MFPH, FFPH, FRSE, and FMedSci. Professor Campbell has held various significant roles, including Joint-Director of the NIHR Global Health Research Unit on Respiratory Health from 2017 to 2026, Co-Editor in Chief of the Journal of Global Health since 2011, and Joint-Director of the WHO Collaborating Centre for Population Health Research & Training since 2013. His previous positions include Deputy Director of the Usher Institute from 2016 to 2021 and Joint-Director of the Centre for Global Health Research from 2015 to 2021. He has also completed UK training posts in paediatrics and infectious diseases and has experience working in Africa, Asia, and the Pacific, including roles as a medical officer and deputy programme manager at WHO Geneva, as well as serving as an NHS Consultant in Public Health. Professor Campbell has a robust research portfolio, with over 700 original articles published in medical journals and recognition as a Highly Cited Researcher in both genetics and social sciences since 2014. His research interests include childhood respiratory infections, colorectal cancer genetics, genetic epidemiology and biobanks, and metabolic psychiatry. He has been involved in significant projects such as the EU IMI programme focusing on RSV disease and the NIHR Global Health Unit on Respiratory Health, which received an NIHR Impact Prize in 2025. His work in colorectal cancer genetics includes leading an EU-funded research consortium and publishing approximately 100 articles in this field. Additionally, he has established population-based studies and biobanks in genetic isolate populations, contributing to over 300 publications in genetic epidemiology. In the area of metabolic psychiatry, Professor Campbell has contributed to developing this research theme in Edinburgh and internationally, leading pilot studies and participating in major trials related to ketogenic diets for mental health. He actively supervises students at both undergraduate and postgraduate levels, including PhD candidates, and has served as an external examiner for various institutions.
Harry Campbell's research encompasses several key areas, primarily focusing on global child health, colorectal cancer genetics, genetic epidemiology, and metabolic psychiatry. In childhood respiratory infections, he has extensive experience and has explored the global burden of disease, disease surveillance, and case management guidelines. He was a founding member and deputy chair of the WHO/UNICEF Child Health Epidemiology Group and has advised WHO and other UN agencies numerous times. His current projects include an EU IMI programme on RSV disease and an NIHR Global Health Unit on Respiratory Health, where he serves as joint co-Director. In colorectal cancer genetics, he has maintained a long-term interest and has held a CRUK Programme grant since 2003. He led an EU-funded research consortium involving genetic isolate populations and has published extensively in this field. His work in genetic epidemiology includes establishing population-based studies and biobanks in genetic isolate populations, supported by MRC Programme Grants. Additionally, he has contributed to the development of metabolic psychiatry, participating in studies on ketogenic diet interventions and serving as an investigator on various mental health research initiatives. He supervises research fellows in this area and is involved in significant trials related to metabolic psychiatry and bipolar depression.